enVVeno Medical Corp (NVNO)
Healthcare
Medical Devices
10.60 $
-0.2%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns enVVeno Medical Corp (NVNO)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 72.8% of the shares are freely tradable; institutional investors hold 25.6%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
25.6%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
13.4%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
72.8%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
2.2%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
1Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Kingdon Capital Management LLC | 5.42 | 36,166 | +0.0 | 03/31/2026 |
| CM Management, LLC | 5.35 | 35,714 | +0.0 | 03/31/2026 |
| Geode Capital Management, LLC | 1.57 | 10,455 | +81.8 | 03/31/2026 |
| Vanguard Group Inc | 1.28 | 299,246 | -65.3 | 12/31/2025 |
| Vanguard Capital Management, LLC | 0.94 | 6,287 | +0.0 | 03/31/2026 |
| JPMorgan Chase & Co | 0.78 | 5,209 | +0.0 | 03/31/2026 |
| Vanguard Fiduciary Trust Co | 0.33 | 2,184 | +0.0 | 03/31/2026 |
| BlackRock Inc | 0.28 | 1,840 | +6.5 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Fidelity Extended Market Index | 1.08 | 7,210 | -0.4 | 04/30/2026 |
| Vanguard Institutional Extnd Mkt Idx Tr | 0.94 | 6,287 | +0.0 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.